ICON PLC Logo

ICON PLC

Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.

ICLR | US

Overview

Corporate Details

ISIN(s):
IE0005711209 (+1 more)
LEI:
Country:
United States of America
Address:
SOUTH COUNTY BUSINESS PARK, 0 DUBLIN 18
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ICON PLC is a global healthcare intelligence and clinical research organization (CRO) that provides outsourced development and commercialization services. The company partners with pharmaceutical, biotechnology, and medical device industries, offering a comprehensive suite of solutions that span the product lifecycle, from molecule to medicine. Key services include clinical development, bioanalytical and specialty laboratory solutions, patient-centric trial recruitment, cardiac safety monitoring, and strategic consulting on market access, pricing, and reimbursement. ICON specializes in providing bespoke, integrated solutions to support drug and device development strategies for its clients worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ICON PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ICON PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ICON PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.